Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > BUSINESS
BUSINESS
- Moderna Takes Over Spikevax’s Japan Marketing Authorization
August 2, 2022
- Japan’s Fertility Treatment Market to Grow 44.4% by 2025: Fuji Keizai
August 1, 2022
- Daiichi Sankyo Q1 Sales Rise 6.2% on Robust Enhertu Performance, Weaker Yen
August 1, 2022
- Otsuka’s H1 Pharma Sales Rise 12% on Global Brands, Profits Drop 26.2%
August 1, 2022
- Sumitomo’s Q1 Sales Zoom 22% on FX, Cancer Drug License Fee
August 1, 2022
- MSD Files 15-Valent Pneumococcal Vaccine for Pediatric Use in Japan
August 1, 2022
- Servier, Yakult to Wind Up Onivyde Promotion Deal in Japan
August 1, 2022
- Alnylam Japan Taps Ex-Galderma Chief Yutaka Okada as New President
July 29, 2022
- Shionogi Out-Licenses South Korea Rights of Cefiderocol to Local Firm
July 29, 2022
- Taiho Files Futibatinib for Biliary Tract Cancer Treatment in Japan
July 29, 2022
- Takeda to Lift Restricted Shipments for Leuplin in September after Over 2 Years
July 29, 2022
- JCR Files Growject for Short Stature due to SHOX Deficiency in Japan
July 29, 2022
- Takeda’s Q1 Sales Up 2.4% Despite Diabetes Divesture Last Year, Gets Hefty FX Gains
July 29, 2022
- Mochida to Quit Filgrastim Biosimilar as Repeated Price Cuts Made It Unprofitable
July 28, 2022
- Bayer, Employee Reach Settlement over Xarelto Scandal
July 28, 2022
- Kissei’s Global Plan for Fibroid Med Hits Snag as ObsEva Seeks Restructuring
July 28, 2022
- Ayumi to Curb Calonal Shipments amid Resurgence in COVID Cases
July 28, 2022
- GSK Japan Foresees 5% Annual Growth by 2026: President Lirette
July 28, 2022
- Horizon Japan Eager for Solo Sales of Its 1st Product as Tepezza Trial Likely to Wrap Up Next Year
July 27, 2022
- Padcev/Keytruda Combo Delivers Positive PIb/II Topline Data for Bladder Cancer: Astellas
July 27, 2022
ページ
Japan is opening a new chapter in sleep medicine. The recent decision to allow medical institutions to advertise “sleep disorders”…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…